Ahls III GP Limited Partnership

This profile gathers the share dealings of Ahls III GP Limited Partnership in Aegerion Pharmaceuticals, Inc. The record holds 13 filings, for trades running from 27 October 2010 to 9 March 2012.

The open-market side counts 1 purchase for €1.8M alongside 9 sales for €3.7M. On balance, insiders were net sellers of €2.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2012 alone, the filings show no purchases and 4 sales.

The record was last updated on 14 March 2012 with an open-market sale (€1.2M) in Aegerion Pharmaceuticals, Inc. The most recent open-market purchase was published on 27 October 2010, 5,857 days ago. Most trades are made public on the day they happen. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.